The new service is aimed at helping the estimated 50,000 firms that this year will need to start paying Philadelphia’s ...
Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to focus on its rare-disease pipeline, which is the subject of ongoing BD ...
Tenaya plans to pursue regulatory alignment on TN-201 pivotal studies over the course of 2026 with an update to be released in the second half of the year. TN-201 was generally well tolerated at both ...
SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant in the Phase 1b FALCON trial has been completed, with initial data expected ...
IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.
BIRMINGHAM, Ala. ( WBRC) - Alabama Attorney General Steve Marshall has announced that the state settled a lawsuit with a ...
When you get IV vitamin infusions outside of a medical setting, it’s difficult to know what’s going into your body and how it ...
Two Americans and astronauts from Japan and Russia landed in a SpaceX capsule in the Pacific Ocean after a medical issue ...
Pricing of $12.5 Million Registered Direct Offering & Concurrent Private Placement Offerings priced at-the-market under ...
Many jails and prisons around the country don't provide medication treatment for opioid use disorder. Studies show that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results